| 李式浩,徐培坤,李显雄,等.术后辅助不同放化疗方案对高级别胶质瘤患者的预后分析[J].安徽医药,2017,21(10):1858-1860. |
| 术后辅助不同放化疗方案对高级别胶质瘤患者的预后分析 |
| The prognostic of high-grade glioma patients in post-operation for different chemoradiotherapy in adjuvant treatment |
| 投稿时间：2017-01-19 |
| DOI： |
| 中文关键词: 高级别胶质瘤 生存期分析 化疗 替莫唑胺 |
| 英文关键词: |
| 基金项目:安徽省科技攻关计划项目(1301042208) |
|
| 摘要点击次数: 5849 |
| 全文下载次数: 1209 |
| 中文摘要: |
| 目的 分析术后辅助放化疗对高级别胶质瘤(HGG)患者生存期的影响。方法 选择手术切除且经病理证实为HGG的患者81例,其中术后辅助替莫唑胺(TMZ)同步放化疗及6个疗程标准化疗(Stupp方案)患者42例,Stupp方案后TMZ继续化疗39例。分析术后不同放化疗方案对患者生存期的临床疗效。结果 Stupp方案后继续化疗组平均生存期31.87个月较Stupp方案化疗组平均生存期24.38个月长(P=0.002),差异有统计学意义。TMZ化疗的不良反应主要发生在前6周期,延长化疗周期并未增加化疗毒性。结论 Stupp方案化疗结束后继续化疗可以延长HGG患者的总生存期(OS)。 |
| 英文摘要: |
| Objective To analyzed the influence of different adjuvant chemoradiotherapy treatment strategies for high-grade glioma (HGG) patients after operation.Methods Selected eighty-one HGG patients proved by pathology.Forty-two cases received post-operative radiotherapy accompanied with chemotherapy and the later of 6 cycles groups chemotherapy (Stupp protocol).Thirty-nine cases was more than 6 cycles groups,to evaluated the curative effect of the two groups survival time.Results The chemotherapy protocol of more than 6 cycles groups average overall survival(OS) was 31.87 months more than 6 cycles groups 24.38 mouths (P=0.002).It had significant difference between the two group.TMZ toxicity was mainly occurred in 6 cycles.No obvious adverse reaction was observed in long-term chemotherapy.Conclusions Continued chemotherapy when the 6 cycles groups finished can increasing the average survival time of HGG patients. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
